Crofelemer for the treatment of secretory diarrhea

Expert Review of Gastroenterology and Hepatology

Volumn 6, Issue 1, 2012, Pages 17-23

  Cottreau, Jessica ^a   Tucker, Anne ^a   Crutchley, Rustin ^a   Garey, Kevin W ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

chloride channel inhibitor; crofelemer; Provir; secretory diarrhea; SP 303

Indexed keywords

ACETORPHAN; BISMUTH SALICYLATE; CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM CHANNEL; CROFELEMER; PLACEBO; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; ZALDARIDE; ZINC;

ABDOMINAL PAIN; ACUTE DIARRHEA; ARTICLE; DIARRHEA; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; FLATULENCE; HERPES SIMPLEX; HUMAN; INFECTIOUS DIARRHEA; IRRITABLE COLON; MOLECULAR PATHOLOGY; ORAL REHYDRATION THERAPY; OUTCOME ASSESSMENT; PATIENT MONITORING; PHYSICAL CHEMISTRY; SECRETORY DIARRHEA; TRAVELLER DIARRHEA;

ANTIDIARRHEALS; CHLORIDE CHANNELS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIARRHEA; DRUG TOXICITY; FEMALE; HUMANS; MALE; PROANTHOCYANIDINS; TRAVEL;

EID: 83455235035     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.11.87     Document Type: Article

References (31)

1. Tradtrantip L, Namkung W, Verkman AS. Crofelemer. An antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels. Mol. Pharmacol. 77(1), 69-78 (2009)
2. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu. Rev. Physiol. 62, 535-572 (2000)
3. Chao AC, de Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P. Activation of intestinal CFTR Cl-channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. 13(5), 1065-1072 (1994)
4. Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol. J. 4, 31 (2007)
5. DiCesare D, DuPont HL, Mathewson JJ, et al. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am. J. Gastroenterol. 97(10), 2585-2588 (2002)
6. Holodniy M, Koch J, Mistal M, et al. A double blind, randomized, placebo-controlled Phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS. Am. J. Gastroenterol. 94(11), 3267-3273 (1999)
7. Mangel AW, Chaturvedi P. Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients. Digestion 78(4), 180-186 (2008)
8. Ericsson CD. Nonantimicrobial agents in the prevention and treatment of travelers diarrhea. Clin. Infect. Dis. 41(Suppl. 8), S557-S563 (2005)
9. Morpeth SC, Thielman NM. Diarrhea in patients with AIDS. Curr. Treat. Options Gastroenterol. 9(1), 23-37 (2006)
10. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. (8), CD003460 (2011)
11. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - A European perspective. Aliment. Pharmacol. Ther. 24(2), 183-205 (2006)
12. Ericsson CD, Tannenbaum C, Charles TT. Antisecretory and antiinflammatory properties of bismuth subsalicylate. Rev. Infect. Dis. 12(Suppl. 1), S16-S20 (1990)
13. DuPont HL, Ericsson CD, Johnson PC, de la Cabada FJ. Use of bismuth subsalicylate for the prevention of travelers diarrhea. Rev. Infect. Dis. 12(Suppl. 1), S64-S67 (1990)
14. Berni Canani R, Secondo A, Passariello A, et al. Zinc inhibits calcium-mediated and nitric oxide-mediated ion secretion in human enterocytes. Eur. J. Pharmacol. 626(2-3), 266-270 (2010)
15. Primi MP, Bueno L, Baumer P, Berard H, Lecomte JM. Racecadotril demonstrates intestinal antisecretory activity in vivo. Aliment. Pharmacol. Ther. 13(Suppl. 6), 3-7 (1999)
16. DuPont HL, Ericsson CD, Mathewson JJ, Marani S, Knellwolf-Cousin AL, Martinez-Sandoval FG. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers diarrhea. Gastroenterology 104(3), 709-715 (1993)
17. Okhuysen PC, DuPont HL, Ericsson CD, et al. Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of travelers diarrhea: randomized, placebo-controlled trial. Clin. Infect. Dis. 21(2), 341-344 (1995)
18. Gabriel SE, Davenport SE, Steagall RJ, Vimal V, Carlson T, Rozhon EJ. A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. Am. J. Physiol. 276(1 Pt 1), G58-G63 (1999)
19. Fischer H, Machen TE, Widdicombe JH, et al. A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells. J. Ethnopharmacol. 93(2-3), 351-357 (2004)
20. Orozco-Topete R, Sierra-Madero J, Cano-Dominguez C, et al. Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS. Antiviral Res. 35(2), 91-103 (1997)
21. Safrin S, McKinley G, McKeough M, Robinson D, Spruance SL. Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303. Antiviral Res. 25(3-4), 185-192 (1994)
22. Wyde P, Meyerson L, Gilbert B. An in vitro evaluation of the antiviral activity of SP-303, an Euphorbiaceae shrub extract, against a panel of respiratory viruses. Drug Dev. Res. 28, 467-472 (1993)
23. Gilbert BE, Wyde PR, Wilson SZ, Meyerson LR. SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Res. 21(1), 37-45 (1993)
24. Barnard DL, Smee DF, Huffman JH, Meyerson LR, Sidwell RW. Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. Chemotherapy 39(3), 203-211 (1993)
25. Barnard DL, Huffman JH, Meyerson LR, Sidwell RW. Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. Chemotherapy 39(3), 212-217 (1993)
26. Ubillas R, Jolad S, Bruening R, et al. SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). Phytomedicine 1, 77-106 (1994)
27. Sidwell RW, Huffman JH, Moscon BJ, Warren RP. Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. Chemotherapy 40(1), 42-50 (1994)
28. Wyde PR, Ambrose MW, Meyerson LR, Gilbert BE. The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats. Antiviral Res. 20(2), 145-154 (1993)
29. Bardhan P, Sharma A, Bolmall C, et al. Safety and efficacy of a novel anti-secretory anti-diarrheal agent crofelemer (NP-303), in the treatment of adult acute infectious diarrhea and cholera, with or without the use of antibiotics. Presented at: US-Japan CMSP: 13th International Conference on Emerging Infectious Diseases (EID) in the Pacific Rim-Focused on Enteric Diseases, Kolkata, India, 6-9 April 2009
30. Crofelemer ADVENT trial demonstrates highly statistically significant results in the treatment of HIV-associated diarrhea. www.salix.com/news-media/ news/ previous-years-news/crofelemer-advent-trial-demonstrates-highly- statistically-significant-results-in-the-treatment-of-hiv-associated-diarrhea. aspx (Accessed 16 November 2011)
31. Safety and Tolerability of Crofelemer in HIV-Associated Diarrhea. www.clinicaltrials.gov/ct2/show/ NCT01374490?term = crofelemer&rank = 2 (Accessed 22 August 2011)